Access to European Union law
<a href="https://eur-lex.europa.eu/content/help/eurlex-content/experimental-features.html" target="_blank">More about the experimental features corner</a>
Choose the experimental features you want to try
EUR-Lex
Access to European Union law

This document is an excerpt from the EUR-Lex website

You are here
Use quotation marks to search for an "exact phrase". Append an asterisk (*) to a search term to find variations of it (transp*, 32019R*). Use a question mark (?) instead of a single character in your search term to find variations of it (ca?e finds case, cane, care).
Search tips
Need more search options? Use the Advanced search

Document C2010/273/03

    Prior notification of a concentration (Case COMP/M.6008 — IK/GHD) — Candidate case for simplified procedure Text with EEA relevance

    SL C 273, 9.10.2010, p. 4–4 (BG, ES, CS, DA, DE, ET, EL, EN, FR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)

    9.10.2010   

    EN

    Official Journal of the European Union

    C 273/4

    Prior notification of a concentration

    (Case COMP/M.6008 — IK/GHD)

    Candidate case for simplified procedure

    (Text with EEA relevance)

    2010/C 273/03

    1.

    On 29 September 2010, the Commission received a notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 (1) by which the IK Investment Partners (‘IK’, the Netherlands) acquire(s) within the meaning of Article 3(1)(b) of the Merger Regulation control of the whole of GHD GesundHeits GmbH Deutschland (GHD, Germany) by way of purchase of shares.

    2.

    The business activities of the undertakings concerned are:

    —

    IK: a European private equity investment firm,

    —

    GHD: active in the provision of medical devices and certain pharmaceutical products to non-hospitalized patients, wholesale of medical devices and pharmaceuticals, provision of logistic services in Germany, as well as production of compounded pharmaceuticals and ostomy products.

    3.

    On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the EC Merger Regulation. However, the final decision on this point is reserved. Pursuant to the Commission Notice on a simplified procedure for treatment of certain concentrations under the EC Merger Regulation (2) it should be noted that this case is a candidate for treatment under the procedure set out in the Notice.

    4.

    The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.

    Observations must reach the Commission not later than 10 days following the date of this publication. Observations can be sent to the Commission by fax (+32 22964301), by email to COMP-MERGER-REGISTRY@ec.europa.eu or by post, under reference number COMP/M.6008 — IK/GHD, to the following address:

    European Commission

    Directorate-General for Competition

    Merger Registry

    J-70

    1049 Bruxelles/Brussel

    BELGIQUE/BELGIË

    (1)  OJ L 24, 29.1.2004, p. 1 (the ‘EC Merger Regulation’).

    (2)  OJ C 56, 5.3.2005, p. 32 (‘Notice on a simplified procedure’).

    Top